Clinical Trials Browser

Phase 2/3 × Pancreatic Neoplasms × Neoadjuvant Therapy × Clear all

NCT01458717 2018-05-02

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

Phase 2/3 Completed

Gastrointestinal

Neoplasms, Pancreatic Neoplasms, Recurrence